Cargando…
Clinical and Laboratory Biomarkers in Paroxysmal Atrial Fibrillation: A Single Center Cross-Sectional Study
The clinical risk profile of paroxysmal atrial fibrillation (pAF) patients is inconclusive. We aimed to identify clinical and laboratory biomarkers in patients with pAF and the differences in biomarkers among genders. A cross-sectional study was conducted with a total of 181 participants in a single...
Autores principales: | Sun, Weiping, Li, Haiwei, Wang, Zefeng, Wu, Yongquan, Du, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259273/ https://www.ncbi.nlm.nih.gov/pubmed/35845733 http://dx.doi.org/10.1155/2022/7012377 |
Ejemplares similares
-
Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation
por: Wang, Zefeng, et al.
Publicado: (2020) -
Elevated tissue inhibitor of metalloproteinase-1 along with left atrium hypertrophy predict atrial fibrillation recurrence after catheter ablation
por: Sun, Weiping, et al.
Publicado: (2022) -
Higher serum tissue inhibitor of metalloproteinase-1 predicts atrial fibrillation recurrence after radiofrequency catheter ablation
por: Li, Haiwei, et al.
Publicado: (2022) -
Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the
Solution to This Elusive Arrhythmia?
por: Howlett, P. J., et al.
Publicado: (2015) -
Sex differences involved in persistent atrial fibrillation recurrence after radiofrequency ablation
por: Li, Haiwei, et al.
Publicado: (2022)